Lee Junning

Theravance Inc.

Sr. VP, Technical Operations

Avg. Two Year Performance

No Purchase Track Record

40% Avg. Sale Return 19% Compound

Holdings: 262.2K shares

Last Three Months: 19-Feb-24 -- 18-May-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

19-May-22 -- 18-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions